Picard Medical (PMI) Cash from Financing Activities (2024 - 2026)

Picard Medical has reported Cash from Financing Activities for 3 years, with the latest figure at -$7.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 365.42% year-over-year to -$7.5 million; the trailing twelve-month figure through Mar 2026 stood at $16.7 million (changed N/A YoY), and the FY2025 full-year result was $27.1 million, up 130.63% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$7.5 million, down from $13.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $13.0 million in Q4 2025, with the low at -$7.5 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged $3.6 million across 3 years, with a median of $2.8 million in 2025.
• Annual changes were most pronounced in 2025 — Cash from Financing Activities jumped 302.63% — and 2026, when it plunged 365.42%.
• Picard Medical's Cash from Financing Activities stood at $3.2 million in 2024, then soared by 302.63% to $13.0 million in 2025, then plunged by 157.79% to -$7.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$7.5 million (Q1 2026), $13.0 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.